Japan Society of Gynecologic Oncology guidelines 2011 for the treatment of uterine cervical cancer
Japan Society of Gynecologic Oncology guidelines 2011 for the treatment of uterine cervical cancer
复制标题
DOI：
10.1007/s10147-015-0806-7
复制
发表时间：
2015-04-01
影响因子：
3.3
通讯作者：
Yoshikawa, Hiroyuki
中科院分区：
文献类型：
--
作者：
Ebina, Yasuhiko;Yaegashi, Nobuo;Yoshikawa, Hiroyuki
2011年出版了《日本妇科肿瘤学会宫颈癌治疗指南》第二版。指导方针包括八章和五种算法。它们是由日本妇科肿瘤学会指南制定委员会和评估委员会成员协商一致编写的，并基于对从文献、医疗保险制度和日本实际临床环境中获得的证据的仔细审查。2011年修订的重点是(1)建议的分级被更改为A、B、C1、C2和D五个阶段；(2)修订与新的国际妇产科联合会分期系统一致；(3)‘日本宫颈癌分类’和新指南之间的角色共享；(4)与腺癌相关的临床问题被修订；(5)增加了关于孕妇宫颈癌的临床问题。每章包括一个临床问题，建议，背景，目标，解释和参考。每项建议都附有建议类别的分类。这些指南的目的是更新宫颈癌的标准治疗策略，从而消除不必要和不充分的治疗。
The second edition of the Japan Society of Gynecologic Oncology guidelines for the treatment of uterine cervical cancer was published in 2011. The guidelines comprise eight chapters and five algorithms. They were prepared by consensus among the members of the Japan Society of Gynecologic Oncology Guidelines Formulation Committee and Evaluation Committee and are based on a careful review of the evidence obtained from the literature, health insurance system, and actual clinical settings in Japan. The highlights of the 2011 revision are (1) the recommended grades have been changed to five stages-A, B, C1, C2, and D; (2) the revisions are consistent with the new International Federation of Gynecology and Obstetrics staging system; (3) the roles are shared between the 'Japanese classification of cervical cancer' and the new guidelines; (4) clinical questions related to adenocarcinoma have been revised; and (5) a clinical question regarding cervical cancer in pregnant patients has been added. Each chapter includes a clinical question, recommendations, background, objectives, explanations, and references. Each recommendation is accompanied by a classification of recommendation categories. The objective of these guidelines is to update the standard treatment strategies for cervical cancer, thus eliminating unnecessary and insufficient treatment.